SOPHiA GENETICS SA Hits New 52-Week High at USD 6.50

SOPHiA GENETICS SA has reached a significant milestone by hitting a new 52-week high of USD 6.50 on July 20, 2026. This achievement marks a notable increase from its 52-week low of USD 2.92, reflecting a robust performance over the past year. The stock has demonstrated a remarkable 31.88% increase in value, significantly outperforming the S&P 500, which has seen a gain of 18.21% during the same period. As a microcap company in the software products industry, SOPHiA GENETICS SA has a market capitalization of USD 337 million. Despite its growth in stock price, the company remains in a loss-making position, with a negative return on equity of -159.46%. The stock's price-to-book ratio stands at 7.14, indicating a premium valuation relative to its book value. Additionally, the company does not offer a dividend, and its debt-to-equity ratio is reported at -0.42. This recent price movement highlights the stock's dynamic activity within the market.